Avsnitt
-
To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal's history, its evolution, and what lies ahead for the future of Neurology®.
Read more about the first 75 years of Neurology®.
Disclosures can be found at Neurology.org.
-
Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care.
Read the related article in Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.
-
Saknas det avsnitt?
-
Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding.
Read the related article in Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.
-
The July 2026 Recall features four previously posted episodes related to updates in epilepsy. The episode opens with Dr. Rosemary Dray-Spira discussing trends in prenatal exposure to antiseizure medications over the past decade. The episode continues with Dr. Page Pennell discussing antiseizure medication management during pregnancy and postpartum. The episode then transitions into a conversation with Dr. Matthew Ryan Woodward on the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment. In the final episode, Dr. Stefano Meletti discusses the incidence and characteristics of postictal central apnea in focal seizures.
Podcast links:
Trends in Prenatal Exposure to Antiseizure Medications
Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD
Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication
Persistent Postictal Central Apnea in Focal Seizures
Article links:
Trends in Prenatal Exposure to Antiseizure Medications Over the Past Decade
A Nationwide StudyAntiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD
Super-Refractory Status Epilepticus Diagnosis, Management, and Prognostication
Persistent Postictal Central Apnea in Focal Seizures
Disclosures can be found at Neurology.org.
-
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent research presented at the 2026 European Stroke Organization Conference.
Read more about TAPIS trial.
Read more about the ODEA-TIA trial.
Disclosures can be found at Neurology.org.
-
Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy.
Read more about this abstract.
Disclosures can be found at Neurology.org.
-
Dr. Stacey Clardy talks with Dr. John Ney about wait times for new neurology office visits among commercially insured persons in the United States.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
-
In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care.
Disclosures can be found at Neurology.org.
-
In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows.
Disclosures can be found at Neurology.org.
-
The June 2026 Recall highlights four previously posted episodes on parkinsonian disorders. The episode begins with Dr. Valtteri Kaasinen discussing the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. The discussion continues with Dr. YuHong Fu, who addresses the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. The third episode features Dr. Daniel Weintraub discussing clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. The episode concludes with Prof. Franziska Hopfner discussing the frequency and disease trajectory of MSA patients who do not experience dysautonomia, compared with those who have autonomic involvement.
Podcast links:
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years
Dementia with Lewy Bodies and Parkinson Disease Dementia
Clinical Approach to Dementia Risk in Patients with Parkinson Disease
Multiple System Atrophy Without Dysautonomia
Article links:
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years
Dementia with Lewy bodies and Parkinson Disease Dementia — The Same or Different and is it Important?
Long-Term Dementia Risk in Parkinson Disease
Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study
Disclosures can be found at Neurology.org.
-
Dr. Gregg Day talks with Drs. Sonia Vallabh and Eric Minikel about scientific insights and the future of prion disease treatment, highlighting the importance of early diagnosis, personalized medicine, and hope for affected families.
Learn about the clinical trial.
Learn more about the Prion Alliance.
Disclosures can be found at Neurology.org.
-
In the second episode of this series, Dr. Tesha Monteith and Dr. Peter Goadsby continue their conversation on advances in headache medicine, including brain health, migraine as a risk factor for dementia, and future directions in neurology.
Disclosures can be found at Neurology.org.
-
In the first part of this series, Dr. Tesha Monteith talks with Dr. Peter Goadsby about some major themes that emerged from the AAN Annual Meeting regarding headache medicine. Disclosures can be found at Neurology.org.
-
Dr. Justin Abbatemarco talks with Dr. Kait Nevel about radiation necrosis following radiation therapy, with a closer look at Boswellia serrata supplement findings.
Please read the related article mentioned in this episode.
Disclosures can be found at Neurology.org.
-
Dr. Alex Menze talks with Dr. Kathryn C. Fitzgerald about using accelerometry to detect subtle, longitudinal changes in disability in people with multiple sclerosis and how these changes relate to brain atrophy and disability progression.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
- Visa fler
